These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 37248653)
1. Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment. Feng A; He L; Jiang J; Chu Y; Zhang Z; Fang K; Wang Z; Li Z; Sun M; Zhao Z; Shi J; Zhang L; Chen T; Xu M Cancer Sci; 2023 Aug; 114(8):3270-3286. PubMed ID: 37248653 [TBL] [Abstract][Full Text] [Related]
2. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma. Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231 [No Abstract] [Full Text] [Related]
3. LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression. Zhao L; Wang G; Qi H; Yu L; Yin H; Sun R; Wang H; Zhu X; Yang A Cell Mol Biol Lett; 2024 May; 29(1):77. PubMed ID: 38769475 [TBL] [Abstract][Full Text] [Related]
4. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells. Ma H; Ma X; Qi L; Zhang Q; Wang T; Guo Q; Li P; Zhang S; Liu S J Gene Med; 2024 Jun; 26(6):e3708. PubMed ID: 38837511 [TBL] [Abstract][Full Text] [Related]
6. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway. Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563 [TBL] [Abstract][Full Text] [Related]
8. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration. Wang C; Li Y; Wang L; Han Y; Gao X; Li T; Liu M; Dai L; Du R Br J Cancer; 2024 May; 130(11):1770-1782. PubMed ID: 38600327 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization. Guo H; Shu J; Hu G; Liu B; Li J; Sun J; Wang X; Liu H; Xiong S; Tang Y; Yin Y; Wang X PLoS One; 2024; 19(5):e0302780. PubMed ID: 38713738 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway. Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020 [TBL] [Abstract][Full Text] [Related]
11. [En1 promotes cell proliferation and migration via Hedgehog signaling pathway in esophageal squamous cell carcinoma]. Zhao N; Gong TY; Wei ZC; Cong J; Liu ZH; Chen HY Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):99-107. PubMed ID: 38418183 [No Abstract] [Full Text] [Related]
12. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway. Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells. Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400 [TBL] [Abstract][Full Text] [Related]
14. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma. Zhang J; Liu S; Zhang D; Ma Z; Sun L J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888 [TBL] [Abstract][Full Text] [Related]
15. [MIR503HG promotes esophageal squamous cell carcinoma cell proliferation, invasion and migration via hsa-miR-503 pathway]. Gong TY; Chen HY; Liu ZH Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1160-1167. PubMed ID: 36380664 [No Abstract] [Full Text] [Related]
16. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels. Chen S; Lin X; He R; Zhang W; Kang M; Xu R Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748 [TBL] [Abstract][Full Text] [Related]
17. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis. Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125 [TBL] [Abstract][Full Text] [Related]
18. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6. Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074 [TBL] [Abstract][Full Text] [Related]
19. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032 [TBL] [Abstract][Full Text] [Related]
20. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase. Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]